CN108059624A - It is used to prepare the preparation method of click azoles amine key intermediate - Google Patents

It is used to prepare the preparation method of click azoles amine key intermediate Download PDF

Info

Publication number
CN108059624A
CN108059624A CN201610980569.8A CN201610980569A CN108059624A CN 108059624 A CN108059624 A CN 108059624A CN 201610980569 A CN201610980569 A CN 201610980569A CN 108059624 A CN108059624 A CN 108059624A
Authority
CN
China
Prior art keywords
acid
formula
solution
nucleopilic reagent
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610980569.8A
Other languages
Chinese (zh)
Inventor
李建其
曾煌
张子学
刘育
潘登
邹磊
张怡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Pharmaceutical Industry
China State Institute of Pharmaceutical Industry
Original Assignee
Shanghai Institute of Pharmaceutical Industry
China State Institute of Pharmaceutical Industry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry filed Critical Shanghai Institute of Pharmaceutical Industry
Priority to CN201610980569.8A priority Critical patent/CN108059624A/en
Publication of CN108059624A publication Critical patent/CN108059624A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/24Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The invention discloses a kind of preparation methods for being used to prepare click azoles amine key intermediate, include the following steps:Formula (4) compound and non-nucleophilic highly basic are acted on, then reacted with (R) Glycidyl butyrate, reaction solution adds in the reactant aqueous solution of nucleopilic reagent solution and acid at room temperature, then from reaction product, collects described formula (1) compound;The present invention replaces aqueous ammonium chloride solution with the aqueous solution of nucleopilic reagent solution and acid, reduces impurity a and b generation, and yield is improved by 65.5% to 78.5%~88.5%.Reaction expression is as follows:

Description

It is used to prepare the preparation method of click azoles amine key intermediate
Technical field
The present invention relates to a kind of preparation methods of click azoles amine key intermediate, and in particular to compound (5R) -3- (4- benzyls Oxygroup -3- fluorophenyls) -5- Qiang Jia Ji oxazolidine -2- ketone (1) preparation method.
Background technology
Click azoles amine (cadazolid) is developed by Actelion companies of Switzerland, is a kind of mosaic type antibacterials, Ju You Evil Oxazolidone and fluoquinolone structure for treating clostridium difficile associated diarrhea, are currently in III phase clinical investigation phase.
(5R) -3- (4- benzyloxy -3- fluorophenyls) -5- Qiang Jia Ji oxazolidine -2- ketone (1) is the key that prepare click azoles amine Intermediate, structural formula are as follows:
At present, the preparation method of the published intermediate is as follows both at home and abroad:
(1) WO2005/058888 disclose one kind (5R) -3- (4- benzyloxy -3- fluorophenyls) -5- Qiang Jia Ji oxazolidines - The preparation method of 2- ketone (1):
It concretely comprises the following steps:The fluoro- 4- nitrobenzenes (2) of 1- benzyloxies -2- through platinum charcoal catalytic hydrogen reduction, acylation, in normal-butyl The lower cyclization of lithium effect obtains formula (1) compound.Route nitro reduction is using expensive platinum carbon catalyst, and the reaction time is long, reference Literature procedures, 48h still can not the reaction was complete;Ring closure reaction temperature requirement is harsh, needs to react at -78 DEG C, equipment requirement is high, yield Only 65.5%.
(2) WO2016/079757 disclose one kind (5R) -3- (4- benzyloxy -3- fluorophenyls) -5- Qiang Jia Ji oxazolidines - The preparation method of 2- ketone (1):
It concretely comprises the following steps:Formula (2) compound is through platinum charcoal catalytic hydrogen reduction, nucleophilic addition, aminoacylates, condensation cyclization etc. Formula (1) compound is obtained by the reaction.The route steps are more, and purification of intermediate is difficult, and nitro reduction need to use expensive platinum charcoal to be catalyzed Agent, the reaction time is long, and hydrogenation equipment requirement is high, is unfavorable for amplification production.
To sum up, formula (1) compound is to prepare an important intermediate of click azoles amine, it has been disclosed that technical method has examination Agent costliness, the shortcomings such as intermediate purity difference, equipment requirement are high, yield is low, it is difficult to carry out industrial amplification production.Therefore, develop The variation route for being suitble to industrialized production is very necessary.
The content of the invention
It is existing to overcome it is an object of the invention to disclose a kind of preparation method for being used to prepare click azoles amine key intermediate There is drawbacks described above existing for technology.
Described to be used to prepare click azoles amine key intermediate, chemical name is (5R) -3- (4- benzyloxy -3- fluorobenzene Base) -5- Qiang Jia Ji oxazolidine -2- ketone, structural formula is as follows:
Preparation method includes the following steps:
Formula (4) compound and non-nucleophilic highly basic are acted on, then reacted under low temperature with (R)-Glycidyl butyrate 0.25h~1.5h, more preferable 0.25~0.5h, reaction solution add in the aqueous solution of nucleopilic reagent solution and acid, reaction at room temperature 0.25~2h removes byproduct of reaction, then from reaction product, collection type (1) compound;
Reaction expression is as follows:
The preferred potassium hexamethyldisilazide of the non-nucleophilic highly basic, sodium hexamethyldisilazide, two silicon of hexamethyl Base amido lithium or lithium diisopropylamine, more preferable hexamethyldisilazide lithium;
Preferably -10~10 DEG C, more preferably -5~5 DEG C of the low temperature;
The nucleopilic reagent is selected from C1~C5Saturated fat alkoxide, preferably potassium tert-butoxide, sodium tert-butoxide, tert-butyl alcohol lithium, methanol Sodium, sodium ethoxide, potassium methoxide, potassium ethoxide, more preferable sodium methoxide;
The preferred C of acid1~C4Aliphatic acid, tartaric acid, maleic acid, malonic acid, ethanedioic acid, adipic acid, sulfuric acid, hydrochloric acid, More preferable hydrochloric acid;
The nucleopilic reagent and the molar ratio preferably 1 of formula (4) compound:3~1:6, more preferable 1:4~1:4.5;The parent The mass fraction of core reagent solution, preferably 20%-30%;
The nucleopilic reagent solution is the organic solvent containing the nucleopilic reagent, and the organic solvent is selected from first Alcohol, ethyl alcohol or the tert-butyl alcohol;
The acid and the molar ratio preferably 1 of formula (4) compound:1.05~1:2.The concentration of aqueous solution preferably 2 of the acid~ 12mol/L, more preferable 3~6mol/L;
It tests and finds with reference to WO2005/058888, this reaction generates substantial amounts of ester by-products (a) and crosses alkylation by-product Object (b), a and b contents respectively may be about 24% and 13% in crude product, and structure is as follows:
And the method for the present invention, the content of by-product a and b in crude product are down to 0.01% and 3% respectively;
The collection method, preferably recrystallizes, the preferred methanol of recrystallization solvent, ethyl alcohol, isopropanol, ethyl acetate, oil Ether, n-hexane and normal heptane knot or its mixture, more preferable isopropanol;
It is prepared by the method that WO2005/058888 document reports can be used in formula (4) compound;
The novelty of the present invention is embodied in:Formula (4) compound is shunk sweet under the effect of non-nucleophilic highly basic with (R)-butyric acid Grease reacts cyclization, sequentially adds the aqueous solution of nucleopilic reagent solution and acid, obtains formula (1) compound.
The beneficial effects of the invention are as follows:
With nucleopilic reagent solution and acid aqueous solution replace aqueous ammonium chloride solution, reduce impurity a and b generate, yield by 65.5% improves to 78.5%~88.5%.
To sum up, the present invention shortens without expensive reducing agent, reaction time, and feed stock conversion improves.Reaction condition is mild, behaviour Make simplicity, it is at low cost, possess the potentiality of industrialized production.
Specific implementation method
It is further illustrated the present invention below by the mode of embodiment, but does not therefore limit the present invention to the reality It applies among a scope.
In embodiment, formula (4) compound is prepared or commercially available using the method for WO2005/058888 document reports It obtains.
Embodiment 1 (5R) -3- (4- benzyloxy -3- fluorophenyls) -5- Qiang Jia Ji oxazolidine -2- ketone (1)
Formula (4) compound (90g, 0.256mol) is added in 900ml anhydrous tetrahydro furans.Two silicon of 1.0M hexamethyls is added dropwise Base lithium amide hexane solution (267ml, 0.269mol), is stirred at room temperature 1h, is cooled to 0 DEG C, adds in R- (-)-glycidol butyric acid Ester (38.7g, 0.269mol) stirs 0.5h, is warmed to room temperature.Add in the methanol solution (32ml) of 30% sodium methoxide, stirring 15min adds 6M hydrochloric acid 43ml.Reaction solution is concentrated under reduced pressure, and obtains white slurry, adds in water (450ml) and dilutes, and filtering obtains To crude white solid (HPLC contents:Impurity a 0.01%, impurity b 3%).It is white that crude product with recrystallisation from isopropanol obtains 71.82g Color solid 1, as described (5R) -3- (4- benzyloxy -3- the fluorophenyls) -5- Qiang Jia Ji oxazolidine -2- ketone (1), yield 88.5%.
ESI-MS(m/z):318[M+H]+
1H NMR(400MHz,CDCl3)δ:7.53-7.29 (m, 6), 7.13-7.04 (m, 1H), 6.97 (t, J=9.0Hz, 1H), 5.12 (s, 2), 4.72 (ddd, J=12.6,7.0,3.7Hz, 1H), 4.13-3.85 (m, 3), 3.86-3.63 (m, 1H), 2.30(s,1H).
Embodiment 2 (5R) -3- (4- benzyloxy -3- fluorophenyls) -5- Qiang Jia Ji oxazolidine -2- ketone (1)
It is operated with reference to WO2005/058888
Formula (4) compound (50g, 0.142mol) is added in 500ml anhydrous tetrahydro furans.2.5M n-BuLis are added dropwise 1h is stirred at room temperature in (6.0ml, 0.149mol), is cooled to -78 DEG C, add in R- (-)-Glycidyl Butyrate (24.6g, 0.171mol).After stirring 0.5h, it is warmed to room temperature.The methanol solution 32ml stirring 15min of 30% sodium methoxide sodium are added in, then are added Enter 6M hydrochloric acid solutions 28ml.Reaction solution vacuum rotary steam, adds in water (250ml, 5 volumes), and filtering obtains faint yellow solid crude product (HPLC contents:Impurity a 24%, impurity b 13%).Crude product obtains 25.9g white solids 1 with recrystallisation from isopropanol, is described (5R) -3- (4- benzyloxy -3- fluorophenyls) -5- Qiang Jia Ji oxazolidine -2- ketone (1), yield 57.5%.
Embodiment 3 (5R) -3- (4- benzyloxy -3- fluorophenyls) -5- Qiang Jia Ji oxazolidine -2- ketone (1)
Formula (4) compound (50g, 0.142mol) is added in 500ml anhydrous tetrahydro furans.2.0M diisopropyl ammonia is added dropwise 1h is stirred at room temperature in base lithium (75ml, 0.149mol), is cooled to -5 DEG C, add in R- (-)-Glycidyl Butyrate (21.54g, 0.149mol).Stir 0.5 it is small when after, be warmed to room temperature.The ethanol solution 18ml stirring 15min of 20% sodium ethoxide are added in, then are added Enter the acetic acid aqueous solution 28ml of 5M.Reaction solution vacuum rotary steam, adds in water (250ml, 5 volumes), and filtering obtains crude white solid (HPLC contents:Impurity a0.11%, impurity b8%).Crude product obtains 35.1g white solids 1 with recrystallisation from isopropanol, is described (5R) -3- (4- benzyloxy -3- fluorophenyls) -5- Qiang Jia Ji oxazolidine -2- ketone (1), yield 78.5%.
Embodiment 4 (5R) -3- (4- benzyloxy -3- fluorophenyls) -5- Qiang Jia Ji oxazolidine -2- ketone (1)
Formula (4) compound (20g, 0.057mol) is added in 200m anhydrous tetrahydro furans.Two silicon of 1.0M hexamethyls is added dropwise Base Sodamide (59ml, 0.059mol) cools down less than -5 DEG C, adds in R- (-)-Glycidyl Butyrate (8.6g, 0.059mol). It is warmed to room temperature after stirring 1.5h, adds in the t-butanol solution 15.9ml stirring 15min of 20% potassium tert-butoxide, add the sulphur of 3M Aqueous acid 19.9ml.By reaction solution vacuum rotary steam, water (100ml, 5 volumes) is added in, filtering obtains crude white solid (HPLC contents:Impurity a0.22%, impurity b12%).Crude product obtains 14.76g white solids 1 with recrystallisation from isopropanol, is described (5R) -3- (4- benzyloxy -3- fluorophenyls) -5- Qiang Jia Ji oxazolidine -2- ketone (1), yield 82%.
Embodiment 5 (5R) -3- (4- benzyloxy -3- fluorophenyls) -5- Qiang Jia Ji oxazolidine -2- ketone (1)
Formula (4) compound (25g, 0.071mol) is added in 250ml anhydrous tetrahydro furans.Two silicon of 1.0M hexamethyls is added dropwise Base potassamide (74ml, 0.074mol), is cooled to less than 5 DEG C, add in R- (-)-Glycidyl Butyrate (10.8g, 0.0748mol).It is warmed to room temperature after stirring 1h, adds in the t-butanol solution 2ml stirring 15min of 20% tert-butyl alcohol lithium, add The aqueous tartaric acid solution 23ml of 3M.By reaction solution vacuum rotary steam, add water (120ml, 5 volumes), filter, obtain crude white solid (HPLC:Impurity a0.12%, impurity b8%).
Crude product obtains 18.05g white solids 1 with recrystallisation from isopropanol, is (5R) -3- (4- benzyloxy -3- fluorobenzene Base) -5- Qiang Jia Ji oxazolidine -2- ketone (1), yield 80%.

Claims (10)

1. it is used to prepare the preparation method of click azoles amine key intermediate, which is characterized in that include the following steps:Formula (4) is changed It closes object to act on non-nucleophilic highly basic, then be reacted with (R)-Glycidyl butyrate, reaction solution adds in nucleophilic examination at room temperature The reactant aqueous solution of agent solution and acid then from reaction product, collects described formula (1) compound;Reaction expression is as follows:
2. according to the method described in claim 1, it is characterized in that, the non-nucleophilic highly basic is selected from two silicon substrate amido of hexamethyl Potassium, sodium hexamethyldisilazide, hexamethyldisilazide lithium or lithium diisopropylamine.
3. according to the method described in claim 1, it is characterized in that, the nucleopilic reagent is selected from C1~C5Saturation fat alkoxide.
4. according to the method described in claim 3, it is characterized in that, the nucleopilic reagent is selected from potassium tert-butoxide, sodium tert-butoxide, uncle Butanol lithium, sodium methoxide, sodium ethoxide, potassium methoxide or potassium ethoxide.
5. according to the method described in claim 2, it is characterized in that, the nucleopilic reagent is selected from C1~C5Saturation fat alkoxide.
6. according to the method described in claim 5, it is characterized in that, the nucleopilic reagent is selected from potassium tert-butoxide, sodium tert-butoxide, uncle Butanol lithium, sodium methoxide, sodium ethoxide, potassium methoxide or potassium ethoxide.
7. according to the method described in claim 1, it is characterized in that, the acid is selected from C1~C4Aliphatic acid, tartaric acid, Malaysia Acid, malonic acid, ethanedioic acid, adipic acid, sulfuric acid or hydrochloric acid.
8. according to claim 1~7 any one of them method, which is characterized in that the nucleopilic reagent and formula (4) compound Molar ratio is 1:3~1:6, the sour molar ratio with formula (4) compound is 1:1.05~1:2, the concentration of aqueous solution of the acid For 2~12mol/L.
9. according to the method described in claim 8, it is characterized in that, the mass fraction of the nucleopilic reagent solution is 20%- 30%.
10. according to claim 1~7 any one of them method, which is characterized in that formula (4) compound and non-nucleophilic is strong Alkali acts on, and then reacts 0.25h~1.5h with (R)-Glycidyl butyrate at -10~10 DEG C, and reaction solution adds at room temperature The aqueous solution of nucleopilic reagent solution and acid reacts 0.25~2h.
CN201610980569.8A 2016-11-08 2016-11-08 It is used to prepare the preparation method of click azoles amine key intermediate Pending CN108059624A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610980569.8A CN108059624A (en) 2016-11-08 2016-11-08 It is used to prepare the preparation method of click azoles amine key intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610980569.8A CN108059624A (en) 2016-11-08 2016-11-08 It is used to prepare the preparation method of click azoles amine key intermediate

Publications (1)

Publication Number Publication Date
CN108059624A true CN108059624A (en) 2018-05-22

Family

ID=62137635

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610980569.8A Pending CN108059624A (en) 2016-11-08 2016-11-08 It is used to prepare the preparation method of click azoles amine key intermediate

Country Status (1)

Country Link
CN (1) CN108059624A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005023801A1 (en) * 2003-09-03 2005-03-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Intermediate products for producing oxazolidinone-quinolone hybrids
WO2005058888A2 (en) * 2003-12-18 2005-06-30 Morphochem Aktiengesellschaft für kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
EP1958941A1 (en) * 2007-02-14 2008-08-20 Lipideon Biotechnology AG Oxazolidinones and their use as hypocholesterolemic agents
CN102177156A (en) * 2008-10-10 2011-09-07 特留斯治疗学公司 Methods for preparing oxazolidinones and compositions containing them
CN103601724A (en) * 2013-11-14 2014-02-26 暨南大学 Novel oxazolidinone compound, as well as preparation method and application thereof
CN105820161A (en) * 2015-01-08 2016-08-03 常州方楠医药技术有限公司 Synthetic method of rivaroxaban intermediate 5-hydroxy methyl oxazolidinone derivative

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005023801A1 (en) * 2003-09-03 2005-03-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Intermediate products for producing oxazolidinone-quinolone hybrids
WO2005058888A2 (en) * 2003-12-18 2005-06-30 Morphochem Aktiengesellschaft für kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
EP1958941A1 (en) * 2007-02-14 2008-08-20 Lipideon Biotechnology AG Oxazolidinones and their use as hypocholesterolemic agents
CN102177156A (en) * 2008-10-10 2011-09-07 特留斯治疗学公司 Methods for preparing oxazolidinones and compositions containing them
CN103601724A (en) * 2013-11-14 2014-02-26 暨南大学 Novel oxazolidinone compound, as well as preparation method and application thereof
CN105820161A (en) * 2015-01-08 2016-08-03 常州方楠医药技术有限公司 Synthetic method of rivaroxaban intermediate 5-hydroxy methyl oxazolidinone derivative

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MARTINE GEHIN ET AL.: "Minimal systemic and high faecal exposure to cadazolid in patients with severe Clostridium difficile infection", 《INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS》 *
曾煌等: "咔哒唑胺的合成", 《中国医药工业杂志》 *
邢其毅 等: "《基础有机化学》", 30 June 2005, 高等教育出版社 *

Similar Documents

Publication Publication Date Title
US20080004447A1 (en) Method for the Synthesis of a Benzimidazole Compound
CN108059624A (en) It is used to prepare the preparation method of click azoles amine key intermediate
CN108129260B (en) Synthesis method of phenyl ethylene glycol
CN101844989B (en) Preparation method for clofedanol and hydrochloride thereof
CN102127061B (en) One prepares improving one's methods of fluoro-3, the 4-dihydro-2 H-1-benzopyran-2-epoxy ethanes of 6-
CN109734616B (en) Method for synthesizing (Z) -3-amino-2- (2-fluoro-3-methoxyphenyl) -2-ethyl crotonate by two-step method
CN110643659B (en) Method for synthesizing decitabine
CN113754602B (en) Synthesis method of 5, 5-dimethyl-4, 5-dihydro-isoxazole-3-one
CN109824661A (en) The preparation method of impurity in a kind of amyl ethyl quin ether hydrochloride
WO2019159871A1 (en) Production method for cyclopentenone derivative
JP6368717B2 (en) Trifluoropyruvate derivative mixture and process for producing the same
US7323607B2 (en) Process for preparation of (+)-p-mentha-2,8-diene-1-ol
JP2014162758A (en) Method for producing high purity dialkyl tartrate
CN100516015C (en) Method for producing 2,2-dichloro or dibromo-phenyl alkyl acetates
EP0312604B1 (en) 1-(2-(4-hydroxybenzoyl)ethanoyl)-2-piperidone, process for its preparation, and alcoholic fermentation accelerator containing it as effective ingredient
CN116655484B (en) Preparation method of L-4-chloro-2-aminobutyric acid ester hydrochloride
US20080027241A1 (en) Process for Producing Cyclopentanone-2, 3, 5-Tricarboxylic Acid Triester
AU640201B2 (en) Preparation of 2,2-dialkoxy cyclic orthoesters derived from lactones
US20040152926A1 (en) Process for producing fluorinated alcohol
CN108069919A (en) The preparation method of click azoles amine key intermediate
CN106478423A (en) Synthesis N, the method for N diisopropylethylamine
CN115677491A (en) Preparation process of ethyl 4- (ethoxycarbonyl) methoxybutyrate
JP2714396B2 (en) Preparation of pyrrolidine derivatives
CN1982268A (en) Production of alkyl iodide by halogen exchange reaction
CN115161670A (en) Method for electrochemically synthesizing 2-acyl aziridine compound

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180522